|
Lupus Erythematosus, Systemic
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Serum malondialdehyde and catalase levels were significantly higher in the SLE group ( p < 0.001).
|
31042126 |
2019 |
|
Lupus Erythematosus, Systemic
|
0.400 |
Biomarker
|
disease |
BEFREE |
Chronic granulomatous disease (CGD) is a rare genetic disorder of neutrophil activity, resulting in increased rate of recurrent infections with catalase-positive bacteria and fungi, as well as various autoimmune diseases such as sarcoidosis, rheumatoid arthritis, and discoid and/or systemic lupus erythematosus.
|
31522454 |
2019 |
|
Lupus Erythematosus, Systemic
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
<b>Conclusion:</b> The results demonstrated a significant lower CAT and GSH levels and also revealed no significant difference for SOD and GPx levels in SLE patients.
|
31475863 |
2019 |
|
Lupus Erythematosus, Systemic
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The catalase activity was higher in SLE patients' neutrophils compared to controls.
|
28163154 |
2017 |
|
Lupus Erythematosus, Systemic
|
0.400 |
Biomarker
|
disease |
CTD_human |
Different end-points to assess effects in systemic lupus erythematosus patients exposed to pesticide mixtures.
|
27497885 |
2017 |
|
Lupus Erythematosus, Systemic
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, the present study supports the notion of in vivo oxidative stress in SLE as indicated by the decrease in CAT activity.
|
22736749 |
2012 |
|
Lupus Erythematosus, Systemic
|
0.400 |
Biomarker
|
disease |
BEFREE |
To evaluate the correlation between oxidative stress and Th1 cytokine level with the disease activity of SLE in the North Indian population, oxidative/anti-oxidant profiles: malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione (GSH) and interferon (IFN)-gamma, interleukin (IL)-12 were studied.
|
20105444 |
2010 |
|
Lupus Erythematosus, Systemic
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our findings suggest that the CAT -330CC genotype may contribute to some clinical manifestations in patients with SLE.
|
18368408 |
2008 |
|
Lupus Erythematosus, Systemic
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
In addition, a positive correlation was observed between anti-CAT Ab and anti-SOD Ab in SLE patients (p<0.05).
|
18415766 |
2008 |
|
Lupus Erythematosus, Systemic
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hence we investigated the effects of a genetic polymorphism of catalase on risk and severity of SLE in 48 pedigrees with African American ancestry.
|
18606005 |
2008 |
|
Lupus Erythematosus, Systemic
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Our findings suggest that the CAT -330CC genotype may contribute to some clinical manifestations in patients with SLE.
|
18368408 |
2008 |
|
Lupus Erythematosus, Systemic
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that genetic polymorphisms of CAT and PPARy2 do not play a significant role in the development of SLE in a Korean population.
|
15934434 |
2005 |